STAT+: Dewpoint Therapeutics, biotech startup in a once-buzzy field, cuts 70% of staff
Dewpoint Therapeutics, a startup working in the once-buzzy field of biomolecular condensates, has laid off most of its staff.
Previous Post
The 15 Medical School Supplies You Need for the New Semester
Next Post
STAT+: DOJ and UnitedHealth reach settlement on $3.3 billion Amedisys deal
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago